As the opioid epidemic flourished across the country between 2006 and 2012, Connecticut’s pharmacies dispensed more than 675 million opioid-based pills.
PhARMA
ACU promotes Trump’s end to drug rebates, CT insurers oppose plan
President Donald Trump wants to end a complex system of drug rebates to lower the cost of medicine, but health insurers say it won’t work.
Trump attempt to rein in drug prices may have limited success
WASHINGTON – The president’s spokesman says Trump still favors a plan to negotiate Medicare prices, but he did not mention it after a recent meeting with pharmaceutical executives, and his plans to speed FDA approval of new drugs may be hampered by his restrictions on new regulations and cuts to the federal workforce.
CT lawmakers push back on pharmaceutical issue in TPP
WASHINGTON – As negotiators for a massive Pacific Rim trade pact meet in Maui for a final round of talks, Connecticut lawmakers are pressing for changes they say will keep the price of key medicines affordable for patients who need them overseas and in the United States.
Malloy urged protection for pharmaceutical firms in trade pact
WASHINGTON – Gov. Dannel P. Malloy and other elected officials lobbied the Obama administration for a provision in the Trans-Pacific Partnership trade pact that would protect pharmaceutical companies making some of the most cutting-edge and expensive drugs against competitors who want to make cheaper, generic versions of those medicines.